glp 1 agonist pharmacology Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation GLP-1 Receptor Agonists as Treatments

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl peptidase-4 inhibitors, according to findings scheduled for presentation at ASCO Annual Meeting

These are not optional add-ons

Hum Mol Genet 2015

Wegovy is used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or with overweight plus a weight-related condition

SUSTAIN-6 evaluated once-weekly semaglutide versus placebo in patients at moderate and high cardiovascular risk with type 2 diabetes, showing a 26% relative risk reduction in MACE (HR 0.74, 95% CI 0.58 to 0.95)

If youre struggling with weight management or managing type 2 diabetes, we encourage you to reach out to us today